Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 9, 2009 - Issue 10
Submit an article Journal homepage
86
Views
10
CrossRef citations to date
0
Altmetric
Review

Treatment options for central nervous system lymphomas in immunocompetent patients

Kristoph Jahnke Department of Hematology and Oncology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany. [email protected]
&
Eckhard Thiel Department of Hematology and Oncology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany. [email protected]
Pages 1497-1509 | Published online: 09 Jan 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Xiao-xiao Wang, Hui-qiang Huang, Bing Bai, Qing-qing Cai, Qi-chun Cai, Yan Gao, Yun-fei Xia, Zhong-jun Xia & Wen-qi Jiang. (2014) Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience. Leukemia & Lymphoma 55:11, pages 2497-2501.
Read now
Gillianne Geet Yi Lai, Yu Xuan Koo, Miriam Tao, Thuan Tong Tan & Soon-Thye Lim. (2011) Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis. Acta Oncologica 50:1, pages 144-145.
Read now

Articles from other publishers (8)

Xuefei Sun, Jing Liu, Yaming Wang, Xueyan Bai, Yuedan Chen, Jun Qian, Hong Zhu, Fusheng Liu, Xiaoguang Qiu, Shengjun Sun, Nan Ji & Yuanbo Liu. (2017) Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma. Oncotarget 8:30, pages 49156-49164.
Crossref
Sarah Catford, Yi Yuen Wang & Rosemary Wong. (2016) Pituitary stalk lesions: systematic review and clinical guidance. Clinical Endocrinology 85:4, pages 507-521.
Crossref
M Linnebank, S Moskau, A Kowoll, A Semmler, C Bangard, M Vogt-Schaden, G Egerer, G Schackert, H Reichmann, I G H Schmidt-Wolf, H Pels & U Schlegel. (2012) Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma. British Journal of Cancer 107:11, pages 1840-1843.
Crossref
Gernot Schulte-Altedorneburg, Lothar Heuser & Hendrik Pels. (2012) MRI patterns in recurrence of primary CNS lymphoma in immunocompetent patients. European Journal of Radiology 81:9, pages 2380-2385.
Crossref
Tali Siegal & Neta Goldschmidt. (2012) CNS prophylaxis in diffuse large B-cell lymphoma: If, when, how and for whom?. Blood Reviews 26:3, pages 97-106.
Crossref
S Donnou, C Galand, C Daussy, L Crozet, W H Fridman, C Sautès-Fridman & S Fisson. (2011) Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristics. Clinical and Experimental Immunology 165:3, pages 329-337.
Crossref
Eckhard Thiel, Agnieszka Korfel, Peter Martus, Lothar Kanz, Frank Griesinger, Michael Rauch, Alexander Röth, Bernd Hertenstein, Theda von Toll, Thomas Hundsberger, Hans-Günther Mergenthaler, Malte Leithäuser, Tobias Birnbaum, Lars Fischer, Kristoph Jahnke, Ulrich Herrlinger, Ludwig Plasswilm, Thomas Nägele, Torsten Pietsch, Michael Bamberg & Michael Weller. (2010) High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. The Lancet Oncology 11:11, pages 1036-1047.
Crossref
Yasuyuki Miyake, Yasushi Okoshi, Takayuki Machino & Shigeru Chiba. (2010) Treatment of central nervous system lymphoma in rats with intraventricular rituximab and serum. International Journal of Hematology 92:3, pages 474-480.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.